|
1
|
Swerdlow M: Mesothelioma of the pelvic
peritoneum resembling papillary cystadenocarcinoma of the ovary;
case report. Am J Obstet Gynecol. 77:197–200. 1959. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bloss JD, Liao SY, Buller RE, Manetta A,
Berman ML, McMeekin S, Bloss LP and DiSaia PJ: Extraovarian
peritoneal serous papillary carcinoma: A case-control retrospective
comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol.
50:347–351. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhuyan P, Mahapatra S, Sethy S, Parida P
and Satpathy S: Extraovarian primary peritoneal papillary serous
carcinoma. Arch Gynecol Obstet. 281:561–564. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pentheroudakis G and Pavlidis N: Serous
papillary peritoneal carcinoma: Unknown primary tumour, ovarian
cancer counterpart or a distinct entity? A systematic review. Crit
Rev Oncol Hematol. 75:27–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goodman MT and Shvetsov YB: Rapidly
increasing incidence of papillary serous carcinoma of the
peritoneum in the United States: Fact or artifact? Int J Cancer.
124:2231–2235. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dubeau L: The cell of origin of ovarian
epithelial tumours. Lancet Oncol. 9:1191–1197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grant DJ, Moorman PG, Akushevich L,
Palmieri RT, Bentley RC and Schildkraut JM: Primary peritoneal and
ovarian cancers: An epidemiological comparative analysis. Cancer
Causes Control. 21:991–998. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao YN, Liu JX, Wang W, Li WF and Tang WS:
Comparison of primary extraovarian peritoneal serous papillary
carcinoma with stage III–IV ovarian papillary serous carcinoma.
Zhonghua Zhong Liu Za Zhi. 27:171–173. 2005.(In Chinese).
PubMed/NCBI
|
|
9
|
Kowalski LD, Kanbour AI, Price FV,
Finkelstein SD, Christopherson WA, Seski JC, Naus GJ, Burnham JA,
KanbourShakir A and Edwards RP: A case-matched molecular comparison
of extraovarian versus primary ovarian adenocarcinoma. Cancer.
79:1587–1594. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cass I, Baldwin RL, Fasylova E, Fields AL,
Klinger HP, Runowicz CD and Karlan BY: Allelotype of papillary
serous peritoneal carcinomas. Gynecol Oncol. 82:69–76. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang LW, Garrett AP, Schorge JO, Muto MG,
Bell DA, Welch WR, Berkowitz RS and Mok SC: Distinct allelic loss
patterns in papillary serous carcinoma of the peritoneum. Am J Clin
Pathol. 114:93–99. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bandera CA, Muto MG, Schorge JO, Berkowitz
RS, Rubin SC and Mok SC: BRCA1 gene mutations in women with
papillary serous carcinoma of the peritoneum. Obstet Gynecol.
92:596–600. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schorge JO, Muto MG, Welch WR, Bandera CA,
Rubin SC, Bell DA, Berkowitz RS and Mok SC: Molecular evidence for
multifocal papillary serous carcinoma of the peritoneum in patients
with germline BRCA1 mutations. J Natl Cancer Inst. 90:841–845.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McBride DJ, Etemadmoghadam D, Cooke SL,
Alsop K, George J, Butler A, Cho J, Galappaththige D, Greenman C,
Howarth KD, et al: Tandem duplication of chromosomal segments is
common in ovarian and breast cancer genomes. J Pathol. 227:446–455.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Castellarin M, Milne K, Zeng T, Tse K,
Mayo M, Zhao Y, Webb JR, Watson PH, Nelson BH and Holt RA: Clonal
evolution of high-grade serous ovarian carcinoma from primary to
recurrent disease. J Pathol. 229:515–524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bashashati A, Ha G, Tone A, Ding J,
Prentice LM, Roth A, Rosner J, Shumansky K, Kalloger S, Senz J, et
al: Distinct evolutionary trajectories of primary high-grade serous
ovarian cancers revealed through spatial mutational profiling. J
Pathol. 231:21–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Winklmeier A, ContrerasShannon V, Arndt S,
Melle C and Bosserhoff AK: Cadherin-7 interacts with melanoma
inhibitory activity protein and negatively modulates melanoma cell
migration. Cancer Sci. 100:261–268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanaka M, Sasaki K, Kamata R, Hoshino Y,
Yanagihara K and Sakai R: A novel RNA-binding protein,
Ossa/C9orf10, regulates activity of Src kinases to protect cells
from oxidative stress-induced apoptosis. Mol Cell Biol. 29:402–413.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leung YK, Mak P, Hassan S and Ho SM:
Estrogen receptor (ER)-beta isoforms: A key to understanding
ER-beta signaling. Proc Natl Acad Sci USA. 103:13162–13167. 2006.
View Article : Google Scholar : PubMed/NCBI
|
